Looks like some interesting debates on health care 3rd party payers are
coming this year in the USA. Full article below.
Terry J. DuBose, M.S., RDMS, FSDMS, FAIUM
4301 West Markham St. Mail Slot #563
--
DuBoseTerryJ@UAMS.edu
http://www.uams.edu/chrp/sonography/
http://www.obgyn.net/us/panel/panel.htm
http://www.io.com/~dubose/
---------------------------------------------------------------
=20
---------------------------------------------------------------
---------------------------------------------------------------
-----Original Message-----
From: Betty [mailto:bhamilt@valornet.com]
Sent: Monday, February 06, 2006 7:30 AM
To: DuBose, Terry
Subject: AWOL from the healthcare debate
Did you happen to see this?
____________________________________________________________
=20
____________________________________________________________
The following appeared on Boston.com:
Headline: AWOL from the healthcare debate
Date: February 6, 2006
"GOVERNOR Mitt Romney's $200 million healthcare proposal no doubt
will create some heated debates. To be fully productive, these debates
must address five issues that no one has wanted to discuss so far."
____________________________________________________________
=20
____________________________________________________________
To see this recommendation, click on the link below or cut and paste it
into a Web browser:
http://www.boston.com/news/globe/editorial_opinion/oped/articles/2006/02
/06/awol_from_the_healthcare_debate?p1=email_to_a_friend
____________________________________________________________
=20
____________________________________________________________
This message was sent by Betty [mailto:bhamilt@valornet.com]
through Boston.com's email recommendation service. If you have questions
or comments about this free service, please email us at
feedback@boston.com.
THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
<http://www.boston.com/news/globe/> <http://www.boston.com/news/globe/>
DAVID W. YOUNG
AWOL from the healthcare debate
By David W. Young | February 6, 2006
GOVERNOR Mitt Romney's $200 million healthcare proposal no doubt will
create some heated debates. To be fully productive, these debates must
address five issues that no one has wanted to discuss so far.
Preventable illness
Should people who maintain their weight subsidize those who do not?
Should nonsmokers subsidize smokers?
According to the Centers for Disease Control, in 1991 there were 49
states that had fewer than 15 percent of their citizens overweight. In
2000, there was only one such state (Colorado).
This obesity epidemic and the resulting high-cost medical conditions are
caused entirely by preventable factors, such as diet and lifestyle.
Similarly, smoking is associated with many high-cost forms of illness.
The solution: Use body-mass indexes and smoking habits to adjust
healthcare premiums.
Family size
Most health plans have two premium levels -- one for single people and
one for married couples. Some include a third level to distinguish
between couples with and without children. In effect, childless couples
and small families subsidize large families.
It's hard to understand the rationale for this pricing policy.
Automobile insurers don't charge one premium for a family with one car
and another for a family with multiple cars. Life insurance companies
charge by the life, not by the family.
There are no economies of scale based on family size -- as it increases,
so, too, does the cost of providing healthcare.
The solution: Charge a separate premium for each individual.
Nonprofit hospitals
Massachusetts, by exempting nonprofit hospitals from property, sales,
excise, and income taxes, provides them with multimillion-dollar annual
subsidies. Although these hospitals complain about the financial burdens
they face in meeting the healthcare needs of the uninsured, they in fact
should be providing such care in exchange for their subsidies.
The solution: Require nonprofit hospitals to pay their tax forgiveness
into a fund to help pay insurance premiums for the uninsured. Hospitals
that provide a great deal of care to the uninsured will receive payments
from the fund in excess of the amount they pay into it; those that
provide little such care will not. The fund will lessen the burden that
otherwise would be placed on the state's taxpayers, and assure everyone
that the new legislation does not create multimillion-dollar annual
windfall gains for nonprofit hospitals.
Physician training
Each of the state's teaching hospitals spends several million dollars a
year on graduate medical education. Yet, only Medicare helps pay for it
from its financially precarious Trust Fund. All other health insurers
are free-riders: They receive the benefit of a cadre of well-trained
physicians at no cost.
The solution: Require health insurers to pay a percentage of their
premiums into a fund for graduate medical education, and reduce
Medicare's medical education payments accordingly.
Pharmaceutical copayments
The substantial cost difference between generic and brand-name drugs is
addressed only minimally by copayments. Copayments also force low-income
patients to choose between filling (or refilling) a prescription and
spending their limited resources on food, clothing, or shelter.
The solution: Eliminate copayments for pharmaceuticals. Instead, when
there is a generic equivalent for a brand-name drug, require patients
who wish to use the brand-name drug to pay the cost difference (rather
than a copayment).
When a Fortune 10 company instituted such a plan, the number of
employees using generic drugs increased from 50 percent to 99 percent.
It should be relatively easy to implement the first two solutions.
Overweight people and smokers have little political clout, and large
families will have a difficult time mobilizing any opposition.
By contrast, the presence of powerful lobbies means that implementing
the last three solutions will require considerable political will.
However, with health insurance premiums and pharmaceutical costs
skyrocketing, the time is ripe for change.
An effort to structure premiums and supplemental payments more fairly
should be welcomed.
If the political will can be mustered to move ahead on these solutions,
each would be relatively easy to implement.
Clearly, some analysis and debate would be required, but in each
instance the overarching premise is to avoid cross-subsidization when
there is no societal benefit to justify it.
If this premise is accepted, the debate can become clearly focused, and
the resulting legislation can eliminate many of the free riders and
opportunists whose self interests underlie much of healthcare inflation.
Perhaps it's time for employers, patients, families, and taxpayers who
currently financially support the vested interests of hospitals,
insurers, and pharmaceutical companies to open their windows and scream
''I'm fed up and won't take it anymore!"
David W. Young is a professor of healthcare management at the Boston
University School of Management.
(c) Copyright <http://www.boston.com/help/bostoncom_info/copyright>
2005 The New York Times Company
==========================
=====================
Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.
==========================
=====================
R0lGODlhBgAIAIABAE5OTgAAACH5BAEAAAEALAAAAAAGAAgAAAIIhI+py+EPXQEAOw==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R0lGODlhggAfAPcAAP///wAAANfX17S0tPv7+/7+/iFGe46Ojk5OTv39/erq6vT09AMDA7q6uvj4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